about
New perspectives of curcumin in cancer prevention.Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer.Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3.Crosstalk from survival to necrotic death coexists in DU-145 cells by curcumin treatment.A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment.Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab.The Concept of Biosimilars: From Characterization to Evolution-A Narrative Review.Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.Autoimmune haemolytic anaemia in a patient with advanced lung adenocarcinoma and chronic lymphocytic leukaemia receiving nivolumab and intravenous immunoglobulin.Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer.Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshopComplete response to ipilimumab and nivolumab therapy in a patient with extensive extrapulmonary high-grade small cell carcinoma of the pancreas and HIV infectionPerspectives: Neutrophil-to-lymphocyte Ratio as a Potential Biomarker in Immune Checkpoint Inhibitor for Non-Small-Cell Lung CancerAssociation of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancerCorrection to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshopClinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung CancerGenomic profiling in pancreatic ductal adenocarcinoma and a pathway towards therapy individualization: A scoping review
P50
Q36957733-22ED4DB6-78B9-42FE-A0A7-0D9C3D811B73Q38991602-9E41692A-F915-4A50-AB5F-D2A6AB6EC44BQ39128337-938BD700-DFF7-42CB-86DB-DD29A7E50BE6Q39204175-F7A480AB-3BB2-4168-8B20-5789163A96F9Q39473604-A93393C5-CDC2-4169-971C-BA274E7D22F6Q47562919-7E709DDB-AC63-4DFB-8371-F780EE38D6C6Q47760510-C9179FA9-1510-429D-8A40-4FD15A23E1DFQ51808006-E4C41D55-D40A-496C-A1EE-FD41084D30D5Q52727544-C2541214-FF70-4AF3-82A8-E7449546A17FQ54977541-6DEEF08E-699A-4DFE-B0F6-0A29369423B2Q64275331-8B4ACFA0-308D-42DB-B4A5-5981AEFF034EQ89478968-874C9728-AB06-4534-AE23-FD82D525E270Q91228268-C51AE982-96AA-4778-8688-C80D6D36CD4CQ91422878-7DD4C435-85E9-49E4-B92F-B12C57E2417CQ91615257-00FC6A42-88E6-4669-A7A2-16F9AB5BD330Q92339671-5BA3F0AD-8C76-4685-A97E-F318469F69EDQ92713234-99E1D2EF-37AA-40E4-B95E-488523FA43A3
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Wungki Park
@en
Wungki Park
@nl
type
label
Wungki Park
@en
Wungki Park
@nl
prefLabel
Wungki Park
@en
Wungki Park
@nl
P31
P496
0000-0002-8006-3102